Literature DB >> 23331385

Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage.

N Feldman1, A Adler, N Molshatzki, S Navon-Venezia, E Khabra, D Cohen, Y Carmeli.   

Abstract

The natural history of KPC-producing Klebsiella pneumoniae (KPC KP) carriage is unknown. We aimed to examine the duration of KPC KP carriage following hospital discharge and to study the risk factors for persistent carriage. A cohort of 125 KPC KP carriers was followed monthly for between 3 and 6 months after discharge from an acute-care hospital. Rectal swabs and data were collected at baseline and at each visit. KPC KP was detected by culture and direct blaKPC PCR. Acquisition time was regarded as the earliest date of KPC KP isolation. Resolution of carriage was defined as a negative KPC KP test in at least two consecutive samples. Analyses were separated for recent (<4 months) (REC, 75 patients) and remote (≥4 months) (REM, 50 patients) acquisition groups. Risk factors for persistent carriage were examined by survival analyses for the REC group and by prevalence methods for the REM group. The mean age of patients was 67.5 years and 49.6% were male. Forty-six (61%) patients in the REC group and 14 (28%) in the REM group were persistent carriers (p < 0.001). A significant risk factor for persistent carriage identified in both the REC and REM groups was the presence of any catheter (p < 0.05). Unique risk factor groups included long-term care facility (LTCF) residence (p < 0.01) and a low functional status as measured by the Barthel's index (p < 0.05) in the REC group and high Charlson's score in the REM group (p < 0.05). Out of the entire 100 patients who had at least one negative sample, only 65 remained negative on subsequent cultures. In conclusion, persistent carriage of KPC KP is associated with catheter use and a low functional status; it is more common in patients with recent acquisition and is related to LTCF stay. A single negative KPC KP test is insufficient to exclude persistent carriage.
© 2012 The Authors Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23331385     DOI: 10.1111/1469-0691.12099

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  34 in total

1.  Clinical Performance of Check-Direct CPE, a Multiplex PCR for Direct Detection of bla(KPC), bla(NDM) and/or bla(VIM), and bla(OXA)-48 from Perirectal Swabs.

Authors:  Anna F Lau; Gary A Fahle; Margaret A Kemp; Agatha N Jassem; John P Dekker; Karen M Frank
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

2.  The Relative Impact of Community and Hospital Antibiotic Use on the Selection of Extended-spectrum Beta-lactamase-producing Escherichia coli.

Authors:  Derek R MacFadden; David N Fisman; William P Hanage; Marc Lipsitch
Journal:  Clin Infect Dis       Date:  2019-06-18       Impact factor: 9.079

3.  Persistence of colonisation with MDRO following discharge from the ICU.

Authors:  Jean-Christophe Lucet; Despoina Koulenti; Jean-Ralph Zahar
Journal:  Intensive Care Med       Date:  2014-03-08       Impact factor: 17.440

4.  Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.

Authors:  Sarah M Bartsch; Susan S Huang; Kim F Wong; Rachel B Slayton; James A McKinnell; Daniel F Sahm; Krystyna Kazmierczak; Leslie E Mueller; John A Jernigan; Bruce Y Lee
Journal:  J Clin Microbiol       Date:  2016-08-31       Impact factor: 5.948

5.  Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: relevance of concomitant systemic antibiotic therapy.

Authors:  Carlo Tascini; Francesco Sbrana; Sarah Flammini; Enrico Tagliaferri; Fabio Arena; Alessandro Leonildi; Ilaria Ciullo; Francesco Amadori; Antonello Di Paolo; Andrea Ripoli; Russell Lewis; Gian Maria Rossolini; Francesco Menichetti
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

6.  Tracking the spread of carbapenem-resistant Enterobacteriaceae (CRE) through clinical cultures alone underestimates the spread of CRE even more than anticipated.

Authors:  Bruce Y Lee; Sarah M Bartsch; Kim F Wong; Diane S Kim; Chenghua Cao; Leslie E Mueller; Gabrielle M Gussin; James A McKinnell; Loren G Miller; Susan S Huang
Journal:  Infect Control Hosp Epidemiol       Date:  2019-03-28       Impact factor: 3.254

7.  Household Transmission of Carbapenemase-producing Enterobacterales in Ontario, Canada.

Authors:  Alainna J Jamal; Amna Faheem; Lubna Farooqi; Xi Zoe Zhong; Irene Armstrong; David A Boyd; Emily Borgundvaag; Brenda L Coleman; Karen Green; Kithsiri Jayasinghe; Jennie Johnstone; Kevin Katz; Philipp Kohler; Angel X Li; Laura Mataseje; Roberto Melano; Matthew P Muller; Michael R Mulvey; Sarah Nayani; Samir N Patel; Aimee Paterson; Susan Poutanen; Anu Rebbapragada; David Richardson; Alicia Sarabia; Shumona Shafinaz; Andrew E Simor; Barbara M Willey; Laura Wisely; Allison J McGeer
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

8.  The pros, cons, and unknowns of search and destroy for carbapenem-resistant enterobacteriaceae.

Authors:  Prashini Moodley; Andrew Whitelaw
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

Review 9.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

10.  Genomic Surveillance Reveals Diversity of Multidrug-Resistant Organism Colonization and Infection: A Prospective Cohort Study in Liver Transplant Recipients.

Authors:  Nenad Macesic; Angela Gomez-Simmonds; Sean B Sullivan; Marla J Giddins; Samantha A Ferguson; Gautam Korakavi; David Leeds; Sarah Park; Kevin Shim; Madeleine G Sowash; Melanie Hofbauer; Ryan Finkel; Yue Hu; Jared West; Nora C Toussaint; William G Greendyke; Benjamin A Miko; Marcus R Pereira; Susan Whittier; Elizabeth C Verna; Anne-Catrin Uhlemann
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.